Intelligent Bio Solutions Inc. (INBS)
Nasdaq · Healthcare · Medical Devices
$1.67+0.60%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $5.5M
- Forward P/E
- 4.8
- 52-week range
- $1.52 – $24.90
- 52-week change
- −84.77%
- EPS (trailing)
- −$8.44
Fiscal year to Jun 2026
- Revenue
- $4.2M (+38.09%)
- Net income
- −$12.4M
- Operating margin
- −299.1%
- Diluted EPS
- −$8.44
- Free cash flow
- −$12.1M
From the company’s annual report on SEC EDGAR.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
Headquarters: New York, United States · 59 employees · ibs.inc